A Case of Lassa Fever Diagnosed at a Community Hospital—Minnesota 2014

Abstract Background In April 2014, a 46-year-old returning traveler from Liberia was transported by emergency medical services to a community hospital in Minnesota with fever and altered mental status. Twenty-four hours later, he developed gingival bleeding. Blood samples tested positive for Lassa fever RNA by reverse transcriptase polymerase chain reaction. Methods Blood and urine samples were obtained from the patient and tested for evidence of Lassa fever virus infection. Hospital infection control personnel and health department personnel reviewed infection control practices with health care personnel. In addition to standard precautions, infection control measures were upgraded to include contact, droplet, and airborne precautions. State and federal public health officials conducted contract tracing activities among family contacts, health care personnel, and fellow airline travelers. Results The patient was discharged from the hospital after 14 days. However, his recovery was complicated by the development of near complete bilateral sensorineural hearing loss. Lassa virus RNA continued to be detected in his urine for several weeks after hospital discharge. State and federal public health authorities identified and monitored individuals who had contact with the patient while he was ill. No secondary cases of Lassa fever were identified among 75 contacts. Conclusions Given the nonspecific presentation of viral hemorrhagic fevers, isolation of ill travelers and consistent implementation of basic infection control measures are key to preventing secondary transmission. When consistently applied, these measures can prevent secondary transmission even if travel history information is not obtained, not immediately available, or the diagnosis of a viral hemorrhagic fever is delayed.

[1]  P. Jahrling,et al.  Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. , 1980, The Journal of infectious diseases.

[2]  N. Gallagher,et al.  Imported case of Marburg hemorrhagic fever - Colorado, 2008. , 2009, MMWR. Morbidity and mortality weekly report.

[3]  J. McCormick,et al.  Lassa fever. Effective therapy with ribavirin. , 1986, The New England journal of medicine.

[4]  P. Jahrling,et al.  Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys. , 1984, The Journal of infectious diseases.

[5]  Kenneth O. Logan,et al.  Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever. , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  K. Johnson,et al.  Lassa fever: response to an imported case. , 1977, The New England journal of medicine.

[7]  D. Bausch,et al.  Review of the Literature and Proposed Guidelines for the Use of Oral Ribavirin as Postexposure Prophylaxis for Lassa Fever , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  A. MacNeil,et al.  Imported Lassa Fever, Pennsylvania, USA, 2010 , 2010, Emerging infectious diseases.

[9]  Jay B. Varkey,et al.  Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States , 2015, Annals of Internal Medicine.

[10]  O. Ogbu,et al.  Lassa fever in West African sub-region: an overview. , 2007, Journal of vector borne diseases.

[11]  F. Hufert,et al.  Detection of Lassa virus RNA in specimens from patients with Lassa fever by using the polymerase chain reaction , 1990, Journal of clinical microbiology.

[12]  J. McCormick,et al.  Lassa fever. Effective therapy with ribavirin. , 1986, The New England journal of medicine.

[13]  J. Frame,et al.  Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. , 1970, The American journal of tropical medicine and hygiene.

[14]  L. Brammer,et al.  Lassa fever in the United States. Investigation of a case and new guidelines for management. , 1990, The New England journal of medicine.

[15]  S. Günther,et al.  Improved Detection of Lassa Virus by Reverse Transcription-PCR Targeting the 5′ Region of S RNA , 2010, Journal of Clinical Microbiology.

[16]  Imported Lassa fever--New Jersey, 2004. , 2004, MMWR. Morbidity and mortality weekly report.

[17]  P. Mead,et al.  Clinical Inquiries Regarding Ebola Virus Disease Received by CDC — United States, July 9–November 15, 2014 , 2014, MMWR. Morbidity and mortality weekly report.

[18]  M. Wolfe,et al.  Historical Lassa Fever Reports and 30-year Clinical Update , 2006, Emerging infectious diseases.

[19]  U. Bauer,et al.  [Centers for Disease Control and Prevention (CDC)]. , 2000, Annales de dermatologie et de venereologie.